Projects per year
Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 55 Similar Profiles
Natural Killer Cells
Medicine & Life Sciences
Fetal Blood
Medicine & Life Sciences
Graft vs Host Disease
Medicine & Life Sciences
Cell Transplantation
Medicine & Life Sciences
Transplantation
Medicine & Life Sciences
Transplants
Medicine & Life Sciences
KIR Receptors
Medicine & Life Sciences
Interleukin-2
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects 1996 2022
Next Generation TriKE Development: EpCAM, otherTriKEs
Miller, J. S., Felices, M. & Vallera, D. A.
10/1/16 → 12/31/19
Project: Research project
Epithelial Cell Adhesion Molecule
myeloid leukemia
natural killer cells
NK Cells, Their Receptors, Transplantation and Cancer Th
Miller, J. S., Cooley, S. A., Ho, Y., Le, C. T., Luo, X., Tolar, J., Vallera, D. A., Verneris, M. R. & Weisdorf, D. J.
NIH NATIONAL CANCER INSTITUTE (NCI)
4/5/16 → 3/31/21
Project: Research project
Natural Killer Cell Receptors
Transplantation
Neoplasms
Therapeutics
Biology and Transplantation of the Hematopoietic Stem Ce
Wagner, J. E., Blazar, B. R., Brunstein, C. G., Cooley, S. A., De For, T. E., Hippen, K. L., Le, C. T., Lindgren, B. R., Luo, X., McKenna, D. H., Miller, J. S., Pennell, C. A., Stefanski, H. E., Tolar, J. & Verneris, M. R.
NIH NATIONAL CANCER INSTITUTE (NCI)
9/25/15 → 8/31/20
Project: Research project
Hematopoietic Stem Cell Transplantation
Transplantation
Targeting Pediatric Sarcoma with Bispecific Toxins and I
Weigel, B. J., Miller, J. S., Vallera, D. A. & Verneris, M. R.
Hope on Wheels Hyundai Dealers
9/18/15 → 9/17/18
Project: Research project
Sarcoma
Immune System
Pediatrics
scorpion toxin I''
Research Output 1991 2018
Absence of early HHV-6 reactivation after cord blood allograft predicts powerful graft-versus-tumor effect
Rashidi, A., Ebadi, M., Said, B., Cao, Q., Shanley, R., Curtsinger, J., Bejanyan, N., Warlick, E. D., Green, J. S., Brunstein, C. G., Miller, J. S. & Weisdorf, D. J., Aug 1 2018, In : American Journal of Hematology. 93, 8, p. 1014-1019 6 p.Research output: Contribution to journal › Article
Fetal Blood
Allografts
Viruses
Transplants
Neoplasms
Adaptive NK cells resist regulatory T-cell suppression driven by IL37
Sarhan, D., Hippen, K. L., Lemire, A., Hying, S., Luo, X., Lenvik, T., Curtsinger, J., Davis, Z., Zhang, B., Cooley, S., Cichocki, F., Blazar, B. R. & Miller, J. S., Jul 1 2018, In : Cancer immunology research. 6, 7, p. 766-775 10 p.Research output: Contribution to journal › Article
Regulatory T-Lymphocytes
Natural Killer Cells
Natural Killer Cell Receptors
Tumor Microenvironment
Programmed Cell Death 1 Receptor
A first-in-human phase I study of subcutaneous outpatient recombinant human IL15 (rhIL15) in adults with advanced solid tumors
Miller, J. S., Morishima, C., McNeel, D. G., Patel, M. R., Kohrt, H. E. K., Thompson, J. A., Sondel, P. M., Wakelee, H. A., Disis, M. L., Kaiser, J. C., Cheever, M. A., Streicher, H., Creekmore, S. P., Waldmann, T. A. & Conlon, K. C., Apr 1 2018, In : Clinical Cancer Research. 24, 7, p. 1525-1535 11 p.Research output: Contribution to journal › Article
Interleukin-15
Outpatients
Neoplasms
Natural Killer Cells
Troponin
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
Wrangle, J. M. , Velcheti, V. , Patel, M. R. , Garrett-Mayer, E. , Hill, E. G. , Ravenel, J. G. , Miller, J. S. , Farhad, M. , Anderton, K. , Lindsey, K. , Taffaro-Neskey, M. , Sherman, C. , Suriano, S. , Swiderska-Syn, M. , Sion, A. , Harris, J. , Edwards, A. R. , Rytlewski, J. A. , Sanders, C. M. , Yusko, E. C. & 9 others , May 1 2018, In : The Lancet Oncology. 19, 5, p. 694-704 11 p.Research output: Contribution to journal › Article
Interleukin-15
Non-Small Cell Lung Carcinoma
Immunotherapy
ALT-803
nivolumab
ALT-803 transiently reduces simian immunodeficiency virus replication in the absence of antiretroviral treatment
Ellis-Connell, A. L., Balgeman, A. J., Zarbock, K. R., Barry, G., Weiler, A., Egan, J. O., Jeng, E. K., Friedrich, T., Miller, J. S., Haase, A. T., Schacker, T. W., Wong, H. C., Rakasz, E. & O'Connor, S. L., Feb 1 2018, In : Journal of Virology. 92, 3, e01748-17Research output: Contribution to journal › Article
Simian immunodeficiency virus
Simian Immunodeficiency Virus
Virus Replication
virus replication
T-lymphocytes